Background With the increased efficacy of stroke treatments, diagnosis and specific
treatment needs of patients with post-stroke seizures (PSS) and post-stroke epilepsy have …

Seizure after stroke or poststroke seizure (PSS) is a common and very important
complication of stroke. It can be divided into early seizure and late seizure, depending on …

Importance Acute symptomatic seizures occurring within 7 days after ischemic stroke may be
associated with an increased mortality and risk of epilepsy. It is unknown whether the type of …

Background The evaluation and management of first-time seizure-like events in children can
be difficult because these episodes are not always directly observed and might be epileptic …

Background and purpose The management of post‐stroke epilepsy (PSE) should ideally
include prevention of both seizure and adverse effects; however, an optimal antiseizure …

Background and Objective Stroke is one of the most frequent neurological syndromes in the
adult population and the cause of 10% of all diagnosed epilepsies. It is attributed to the …

The effects of thrombolysis in seizure and epilepsy after acute ischemic stroke have been
poorly explored. In this study, we examine risk factors and consequences of intravenous rt …

Poststroke epilepsy is a major ischaemic/haemorrhagic stroke complication. Seizure
recurrence risk estimation and early therapeutic intervention are critical, given the …

Seizures and epilepsy are quite a common outcome of arterial ischemic stroke (AIS) both in
pediatric and adult patients, with distinctly higher occurrence in children. These poststroke …

Vinpocetine (VPN) is a synthetic ethyl-ester derivative of the alkaloid apovincamine from
Vinca minor leaves. VPN is a selective inhibitor of phosphodiesterase type 1 (PDE1) that …